NEW YORK (Reuters) - Chimerix Inc shares were briskly traded before the opening bell on Wednesday as an experimental oral antiviral drug improved the survival rate of patients with a certain type of respiratory infection, according to preliminary data.
NEW YORK (Reuters) - Actavis Plc plans to approach Allergan Inc again about a potential merger, as the Botox maker warms up to the possibility of a sale, people familiar with the matter said on Tuesday.
MAPLE PARK Ill. (Reuters) - Chris Gould's combine cab is loaded like the cockpit of a fighter jet he used to fly as he harvests soybeans in northern Illinois, steered by satellites, four video screens glowing with up to minute updates about his crop and the work's progress.
SAN FRANCISCO/TOKYO (Reuters) - The financial implosion of Apple Inc supplier GT Advanced Technologies Inc this week offers a dramatic illustration of how the iPhone maker can put the screws to suppliers willing to take a short-term risk for future riches.
BERLIN (Reuters) - German sportswear firm Adidas has appointed two new senior managers as part of an ongoing overhaul of its top leadership aimed at making the firm quicker to respond to consumer trends to keep up with bigger rival Nike .
ZURICH (Reuters) - The bosses of drugmakers Roche and Novartis both earned more than 13 million Swiss francs ($13.6 million) last year, according to a study published on Wednesday, 18 months after the Swiss voted for some of the world's strictest controls on executive pay.
PARIS (Reuters) - Air France-KLM has put the total cost of last month's two-week pilots strike at 500 million euros ($632 million), enough to wipe more than a fifth off the group's estimated full-year core profit and sending its shares to a 13-month low.
SEOUL (Reuters) - Already the world's biggest duty-free market, South Korea said on Wednesday it will issue more licenses for downtown duty-free shops, doubling down on a strategy that has helped it outstrip regional rivals seeking to reel in shopaholic Chinese tourists.
LONDON/MOSCOW (Reuters) - VTB Capital, the investment arm of sanctioned Russian lender VTB Bank , has made a cash payment to secure a deal to buy most of Italian fashion house Roberto Cavalli before the end of November, two sources familiar with the situation said.